Physician profile
Bryce A Kruman
NPI 1730703711
$15,024.32
in general payments reported to CMS, 2019-2025
17 companies · $7,358 in 2025
The $7,358 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $577 · 2023: $735 · 2024: $6,354 · 2025: $7,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,536 · Food and Beverage: $4,156 · Education: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,535.88 |
| Food and Beverage | $4,156.23 |
| Education | $754.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $4,763.05 | 2024-2025 | Truelok, Tl-Hex Truelok Hexapod System |
| Paragon 28, INC. | $3,543.77 | 2022-2025 | Portfolio, Monkey Rings, R3flex |
| Stryker Corporation | $2,224.44 | 2022-2025 | Hoffmann, Ortholoc 3di, Ezout |
| Arthrex, INC. | $1,527.20 | 2025 | |
| Medical Device Business Services, INC. | $964.96 | 2022-2025 | Actis |
| Novus Surgical Consultants | $641.93 | 2024-2025 | |
| Integra Lifesciences Corporation | $376.84 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $182.50 | 2023-2025 | |
| Nevro Corp. | $133.95 | 2023 | Senza |
| Trice Medical, INC. | $125.03 | 2025 | |
| Amgen INC. | $124.74 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $108.80 | 2022 | |
| Bone Support INC. | $89.69 | 2025 | Cerament G, Ceramentbone Void Filler |
| Crossroads Orthopedics, LLC | $88.26 | 2022-2024 | |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43.12 | 2024 | Stravix |
| Solventum Corporation | $28.04 | 2024 | V.A.C. Veraflo, V.A.C.Instill, V.A.C. Granufoam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Kruman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.